Research graph
References from Ultrasound-based shrinkage patterns at mid-neoadjuvant chemotherapy for predicting pathological complete response in invasive breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Chinese breast cancer neoadjuvant chemotherapy expert consensus (2022 edition)
2022 · External reference
Association of tumor-infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
10.1002/cam4.4302 · 2021 · External reference
Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: A comprehensive meta-analysis
10.1158/1078-0432.ccr-19-3492 · 2020 · External reference
MRI and radiomics in assessing the efficacy of neoadjuvant therapy for different molecular subtypes of breast cancer: Progress in research
2023 · External reference
Advances in imaging prediction of prognosis and neoadjuvant chemotherapy response in breast cancer
2020 · External reference
Multimodality imaging review of HER-2-positive breast cancer and response to neoadjuvant chemotherapy
10.1148/rg.220103 · 2023 · External reference
Applications of ultrasound radiomics in breast tumor research
2023 · External reference
Magnetic resonance imaging patterns of tumor shrinkage after neoadjuvant chemotherapy in breast cancer patients: Correlation with pathological response grading system based on tumor cellularity
10.1177/0284185113498720 · 2012 · External reference
Research progress on tumor shrinkage patterns after neoadjuvant chemotherapy in breast cancer
2022 · External reference
Research progress on tumor shrinkage patterns after neoadjuvant treatment in breast cancer
2024 · External reference
Magnetic resonance imaging tumor shrinkage shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: Correlation with tumor biological subtypes and pathological response after therapy
10.1177/1010428317694540 · 2017 · External reference
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
10.1186/s13058-018-0950-x · 2018 · External reference
Mid-treatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple-negative breast cancer
10.1016/j.ultrasmedbio.2022.01.018 · 2022 · External reference
Multiparametric MRI radiomics fusion for predicting the response and shrinkage pattern to neoadjuvant chemotherapy in breast cancer
10.3389/fonc.2023.1057841 · 2023 · External reference
MRI-based tumor shrinkage patterns after early neoadjuvant therapy in breast cancer: Correlation with molecular subtypes and pathological response after therapy
10.1186/s13058-024-01781-1 · 2024 · External reference
Mutant allele frequency based intra tumoral genetic heterogeneity related to the tumor shrinkage mode after neoadjuvant chemotherapy in breast cancer patients
10.3389/fmed.2021.651904 · 2021 · External reference
Study on the correlation between tumor shrinkage patterns and tumor heterogeneity after neoadjuvant chemotherapy in breast cancer
2022 · External reference
Research on tumor shrinkage patterns after neoadjuvant chemotherapy in breast cancer
2018 · External reference
Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge
10.3390/cells8090957 · 2019 · External reference
Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: A pilot study
10.1038/s41598-023-36315-w · 2023 · External reference
Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER-2-positive breast cancer
10.1007/s12282-021-01220-5 · 2021 · External reference
The role of nomogram based on the combination of ultrasound parameters and clinical indicators in the degree of pathological remission of breast cancer
10.1155/2023/3077180 · 2023 · External reference
Multimodal ultrasound features predicting Ki-67 expression levels in lump-type breast cancer
2023 · External reference
18F]FDG PET/CT volumetric biomarkers for non-invasive prediction of HER-2 expression in breast cancer patients
10.22038/aojnmb.2024.79970.1563 · 2025 · External reference
Predictive markers for pathological complete response (pCR) after neo-adjuvant chemotherapy in HER-2-positive breast carcinoma
10.14670/hh-18-626 · 2024 · External reference
Predicting pathological complete response after neoadjuvant chemotherapy: A nomogram combining clinical features and ultrasound semantics in patients with invasive breast cancer
10.3389/fonc.2023.1117538 · 2023 · External reference
